Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective.
COVID-19
SARS-CoV-2
antibiotics
long COVID
risk factor
tachycardia
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
09 Jan 2023
09 Jan 2023
Historique:
received:
11
11
2022
revised:
03
01
2023
accepted:
05
01
2023
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
22
1
2023
Statut:
epublish
Résumé
Risk factors for developing long COVID are not clearly established. The present study was designed to determine if any sign, symptom, or treatment of the acute phase, or personal characteristics of the patient, is associated with the development of long COVID. A cohort study was carried out, randomly selecting symptomatic COVID-19 patients and not vaccinated. The severity of the acute illness was assessed through the number of compatible COVID-19 symptoms, hospitalizations, and the symptom severity score using a 10-point visual analog scale. After multivariate analysis, a severity score ≥8 (RR 2.0, 95%CI 1.1-3.5, Further studies in diverse populations over time are needed to expand the knowledge that could lead us to prevent and/or treat long COVID.
Sections du résumé
BACKGROUND
BACKGROUND
Risk factors for developing long COVID are not clearly established. The present study was designed to determine if any sign, symptom, or treatment of the acute phase, or personal characteristics of the patient, is associated with the development of long COVID.
METHODS
METHODS
A cohort study was carried out, randomly selecting symptomatic COVID-19 patients and not vaccinated. The severity of the acute illness was assessed through the number of compatible COVID-19 symptoms, hospitalizations, and the symptom severity score using a 10-point visual analog scale.
RESULTS
RESULTS
After multivariate analysis, a severity score ≥8 (RR 2.0, 95%CI 1.1-3.5,
CONCLUSIONS
CONCLUSIONS
Further studies in diverse populations over time are needed to expand the knowledge that could lead us to prevent and/or treat long COVID.
Identifiants
pubmed: 36673565
pii: healthcare11020197
doi: 10.3390/healthcare11020197
pmc: PMC9858709
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Consejo Nacional de Ciencia y Tecnología
ID : 319282
Références
Front Cell Infect Microbiol. 2021 Nov 02;11:767771
pubmed: 34796130
Am J Epidemiol. 1986 Jan;123(1):174-84
pubmed: 3509965
Gut. 2022 Mar;71(3):544-552
pubmed: 35082169
Nutrients. 2022 Jan 10;14(2):
pubmed: 35057455
Infect Dis (Lond). 2022 Dec;54(12):897-908
pubmed: 36036090
Front Public Health. 2020 Jun 26;8:337
pubmed: 32671012
Ther Adv Infect Dis. 2022 Jan 11;9:20499361211069264
pubmed: 35059196
Sci Rep. 2022 Jan 7;12(1):298
pubmed: 34996973
Nat Med. 2022 Aug;28(8):1706-1714
pubmed: 35879616
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
J Clin Med. 2022 Mar 07;11(5):
pubmed: 35268554
Sci Rep. 2020 Jul 24;10(1):12567
pubmed: 32709854
Exp Ther Med. 2021 Sep;22(3):915
pubmed: 34306189
SAGE Open Med. 2021 Oct 29;9:20503121211054973
pubmed: 34733514
Clin Rheumatol. 2020 Jul;39(7):2103-2104
pubmed: 32458242
Adv Skin Wound Care. 2020 Dec;33(12):1-5
pubmed: 33208633
Ann Intern Med. 2020 Oct 20;173(8):623-631
pubmed: 32673060
Semin Vasc Surg. 2021 Sep;34(3):125-131
pubmed: 34642032
Am J Epidemiol. 2003 May 15;157(10):940-3
pubmed: 12746247
BMJ. 2004 Jul 24;329(7459):209-13
pubmed: 15271832
Front Cell Neurosci. 2017 Dec 22;11:419
pubmed: 29311839
PLoS One. 2022 Mar 31;17(3):e0266175
pubmed: 35358268
Elife. 2020 May 11;9:
pubmed: 32392129
Lancet Glob Health. 2020 Aug;8(8):e1018-e1026
pubmed: 32622400
Nat Med. 2022 Jul;28(7):1461-1467
pubmed: 35614233
Ann Hematol. 2020 Sep;99(9):2113-2118
pubmed: 32656591
Heliyon. 2021 Jan;7(1):e06008
pubmed: 33495739
J Infect Dis. 2022 Nov 1;226(9):1593-1607
pubmed: 35429399
Cell. 2022 Mar 3;185(5):881-895.e20
pubmed: 35216672
BMJ. 2018 Feb 22;360:k757
pubmed: 29472187
BMC Med Res Methodol. 2012 Feb 15;12:14
pubmed: 22335836
JAMA Intern Med. 2022 Oct 1;182(10):1071-1081
pubmed: 36074486
EClinicalMedicine. 2022 Aug 27;53:101624
pubmed: 36051247
Iran J Med Sci. 2021 Nov;46(6):428-436
pubmed: 34840383
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Biomed Rep. 2022 Nov 17;18(1):4
pubmed: 36544852
BMJ. 2021 Jul 26;374:n1648
pubmed: 34312178
Transfusion. 2023 Jan;63(1):47-58
pubmed: 36271437
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998
pubmed: 32730238